Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease

dc.creatorUddin M.S.
dc.creatorKabir M.T.
dc.creatorMamun A.A.
dc.creatorBarreto G.E.
dc.creatorRashid M.
dc.creatorPerveen A.
dc.creatorAshraf G.M.
dc.date.accessioned2020-09-02T22:29:29Z
dc.date.accessioned2022-11-08T20:19:32Z
dc.date.available2020-09-02T22:29:29Z
dc.date.available2022-11-08T20:19:32Z
dc.date.created2020-09-02T22:29:29Z
dc.date.issued2020
dc.identifier84, , -
dc.identifier15675769
dc.identifierhttps://hdl.handle.net/20.500.12728/6464
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5143215
dc.languageen
dc.publisherElsevier B.V.
dc.subjectAlzheimer's disease
dc.subjectAnti-inflammatory agents
dc.subjectImmune system
dc.subjectNeuroinflammation
dc.subjectProinflammatory molecules
dc.subjectadvanced glycation end product receptor
dc.subjectamyloid beta protein
dc.subjectangiotensin 1 receptor
dc.subjectantiinflammatory agent
dc.subjectazeliragon
dc.subjectcandesartan
dc.subjectcytokine
dc.subjectetanercept
dc.subjectgc 021109
dc.subjectgranulocyte macrophage colony stimulating factor
dc.subjectimmunoglobulin
dc.subjectminocycline
dc.subjectneflamapimod
dc.subjectnonsteroid antiinflammatory agent
dc.subjectnootropic agent
dc.subjectpioglitazone
dc.subjectprostaglandin synthase
dc.subjectrosiglitazone
dc.subjectsargramostim
dc.subjecttelmisartan
dc.subjectthalidomide
dc.subjectunclassified drug
dc.subjectAlzheimer disease
dc.subjectantiinflammatory activity
dc.subjectcytokine release
dc.subjectdisease exacerbation
dc.subjectdrug targeting
dc.subjecthuman
dc.subjectinsulin resistance
dc.subjectmacroglia
dc.subjectmediator
dc.subjectmicroglia
dc.subjectmononuclear cell
dc.subjectnerve cell
dc.subjectnervous system inflammation
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectprotein expression
dc.subjectReview
dc.subjectsignal transduction
dc.titlePharmacological approaches to mitigate neuroinflammation in Alzheimer's disease
dc.typeReview


Este ítem pertenece a la siguiente institución